Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million
June 07, 2019 05:41 ET
|
Biogen Inc.
CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) today announced that it has completed its acquisition of Nightstar Therapeutics (NST; Nasdaq: NITE), a clinical-stage gene...